RESEARCH PAPER
The effect of appointment spacing model of care on virological suppression and associated factors among HIV-positive individuals on antiretroviral therapy at public health facilities of Debre Markos town, Northwest Ethiopia: interrupted time series design
1
Department of Public Health, College of Health Science, Debre Markos University, Debre Markos, Ethiopia
2
CDC Monitoring and Evaluation Officer, Bahir Dar, Amhara Regional State, Ethiopia
Submission date: 2022-02-17
Final revision date: 2022-03-23
Acceptance date: 2022-03-29
Publication date: 2024-02-22
HIV & AIDS Review 2024;23(1):37-44
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Appointment spacing model (ASM) of care is crucial for human immunodeficiency viruses (HIV) patients receiving antiretroviral therapy in order to improve service quality and patient’s clinical outcomes, including viral suppression. However, there is a paucity of information about the effectiveness of ASM on viral suppression. Therefore, this study aimed to assess the level and trends of virological suppression and associated factors among patients on antiretroviral therapy enrolled into ASM in Northwest Ethiopia.
Material and methods:
An interrupted time series study design was conducted among 272 adult HIV-positive patients, who were stable and enrolled into ASM. They were selected by using a systematic random sampling technique. Data were collected from patients’ charts, registration books, and computer databases using abstraction sheets. Regression coefficients with a 95% confidence interval (CI) computed, and variables having less than p-value = 0.05 in the segmented regression model were considered significant predictors of virological suppression.
Results:
This study revealed that virological suppression was decreased from the baseline of 99.22% to 96% after the implementation of ASM. The trends of virological suppression were significantly decreased by 1.38 (95% CI: –2.2, –0.5%, p = 0.0007) after the implementation of ASM. Poor adherence was the most influential variable that caused level and trend decrements over time (p = 0.04).
Conclusions:
The level of virological suppression was significantly reduced after the implementation of ASM. The most significant factor associated with decreased levels and trends over time was poor adherence. It would be beneficial to assess and maintain good adherence of patients on antiretroviral therapy throughout the clinical visit during the implementation of ASM.
Appointment spacing model (ASM) of care is crucial for human immunodeficiency viruses (HIV) patients receiving antiretroviral therapy in order to improve service quality and patient’s clinical outcomes, including viral suppression. However, there is a paucity of information about the effectiveness of ASM on viral suppression. Therefore, this study aimed to assess the level and trends of virological suppression and associated factors among patients on antiretroviral therapy enrolled into ASM in Northwest Ethiopia.
Material and methods:
An interrupted time series study design was conducted among 272 adult HIV-positive patients, who were stable and enrolled into ASM. They were selected by using a systematic random sampling technique. Data were collected from patients’ charts, registration books, and computer databases using abstraction sheets. Regression coefficients with a 95% confidence interval (CI) computed, and variables having less than p-value = 0.05 in the segmented regression model were considered significant predictors of virological suppression.
Results:
This study revealed that virological suppression was decreased from the baseline of 99.22% to 96% after the implementation of ASM. The trends of virological suppression were significantly decreased by 1.38 (95% CI: –2.2, –0.5%, p = 0.0007) after the implementation of ASM. Poor adherence was the most influential variable that caused level and trend decrements over time (p = 0.04).
Conclusions:
The level of virological suppression was significantly reduced after the implementation of ASM. The most significant factor associated with decreased levels and trends over time was poor adherence. It would be beneficial to assess and maintain good adherence of patients on antiretroviral therapy throughout the clinical visit during the implementation of ASM.
REFERENCES (46)
1.
Federal Ministry of Health of Ethiopia. National consolidated guidelines for comprehensive HIV prevention, care and treatment; 2018. Available at: https://www.afro.who.int/publi....
3.
Ministry of Health. HIV/AIDS in Ethiopia. Ethiopia Demographic and Health Survey; 2011. Available at: https://www.afro.who.int/healt....
4.
UNAIDs. Understanding fast-track. Accelerating action to end the AIDS epidemic by 2030. Geneva: UNAIDs; 2019. Available at: https://www.unaids.org/en/reso....
5.
PEPFAR. Ethiopia Country Operational Plan COP 2020/ FY 2021: Strategic Direction Summary. 2020; Available from: https://www.pepfar.gov/documen....
6.
Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health 2016; 1: e000010. DOI: 10.1136/bmjgh-2015-000010.
8.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2nd ed. Geneva: WHO; 2016. Available at: https://www.who.int/publicatio....
9.
World Health Organization. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. Geneva: WHO; 2017. Available at: https://www.who.int/publicatio....
10.
World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy – policy brief. Geneva: WHO; 2017. Available at: https://www.who.int/publicatio....
11.
World Health Organization. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva: WHO; 2014. Available at: https://www.paho.org/en/node/6....
12.
Bvochora T, Satyanarayana S, Takarinda KC, et al. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: operational issues. PLoS One 2019; 14: e0211326. DOI: https://doi.org/10.1371/journa....
13.
Assefa Y, Gilks CF, Dean J, et al. Towards achieving the fast-track targets and ending the epidemic of HIV/AIDS in Ethiopia: successes and challenges. Int J Infect Dis 2019; 78: 57-64.
14.
Desta AA, Woldearegay TW, Futwi N, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis 2020; 20: 4. DOI: 10.1186/s12879-019-4732-6.
15.
Mainaa EK, Mureithia H, Adana AA, Muriukib J, Lwembeb RM, Bukusi EA. Incidence and factors associated with viral suppression among HIV patients on HAART in Kenya. Int J Infect Dis 2020; 97: 151-158.
16.
Eberhart MG, Yehia BR, Hillier A, et al. Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. J Acquir Immune Defic Syndr 2015; 69 Suppl 1: S37-S43.
17.
Feleke R, Geda B, Roba KT, Weldegebreal F. Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia. SAGE Open Med 2020; 8: 2050312120906076. DOI: 10.1177/2050312120906076.
18.
Long L, Kuchukhidze S, Pascoe S, et al. Retention in care and viral suppression in differentiated service delivery models for HIV treatment in sub-Saharan Africa: a rapid systematic review. J Int AIDS Soc 2020; 23: e25640. DOI: 10.1002/jia2.25640.
19.
World Health Organization. Consolidated Guideline on HIV Prevention, Diagnosis, Treatment and Care for Key Populations 2016. Geneva: WHO; 2016. Available at: https://www.who.int/publicatio....
20.
Assefa T, Melaku Z, Amdino W, et al. Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges. ICAP Ethiopia, Columbia University; 2017.
21.
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 2017; 46: 348-355.
22.
Maru M, Dagne D, Tesfie A, Missaye A, Yismaw G, Mulu A. Increased viral suppression among people on first line antiretroviral treatment in Ethiopia: meeting the third 90’s. Research Square; 2020. DOI: 10.21203/rs.2.20431/v1.
23.
Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS One 2018; 13: e0196259. DOI: 10.1371/journal.pone.0196259.
24.
Bulage L, Ssewanyana I, Nankabirwa V, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014-July 2015. BMC Infect Dis 2017; 17: 326. DOI: 10.1186/s12879-017-2428-3.
25.
Gaolathe T, Wirth KE, Pretorius Holme M, et al. Botswana’s progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV 2016; 3: e221-e230. doi: 10.1016/S2352-3018(16)00037-0.
26.
Haider MR, Brown MJ, Harrison S, et al. Sociodemographic factors affecting viral load suppression among people living with HIV in South Carolina. AIDS Care 2021; 33: 290-298.
27.
Cesar C, Jenkins CA, Shepherd BE, et al. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study. Lancet HIV 2015; 2: e492-e500. DOI: 10.1016/S2352-3018(15)00183-6.
28.
Edun B, Iyer M, Albrecht H, Weissman S. The South Carolina rural-urban HIV continuum of care. AIDS Care 2017; 29: 817-822.
29.
Melku M, Abebe G, Teketel A, et al. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy. Environ Health Prev Med 2020; 25: 43. DOI: 10.1186/s12199-020-00881-6.
30.
Gelaw YA, Biks GA, Alene KA. Effect of residence on mothers’ health care seeking behavior for common childhood illness in Northwest Ethiopia: a community based comparative cross-sectional study. BMC Res Notes 2014; 7: 705. DOI: 10.1186/1756-0500-7-705.
31.
Fantahun M, Kumbi S, Degu G, et al. Dabat rural health project, North west Ethiopia: report of the baseline survey. Ethiop J Health Dev 2001; 15. DOI: 10.4314/ejhd.v15i1.46860.
32.
Olukolade R, Abiodun Q, Ogbuji QC, et al. Role of treatment supporters beyond monitoring daily drug intake for TB-patients: findings from a qualitative study in Nigeria. J Public Health Epidemiol 2017; 9: 65-73.
33.
Mayanja B, Kabunga E, Masiira B, Lubega R, Kaleebu P, Seeley J. Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort. Afr Health Sci 2013; 13: 311-319.
34.
Yaya I, Landoh DE, Saka B, et al. Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health 2014; 14: 1308. DOI: 10.1186/1471-2458-14-1308.
35.
Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr 2013; 63: 112-119.
36.
Kiyingi K, Lauwo J. Drugs in the home: danger and waste. World Health Forum 1993; 14: 381-384.
37.
Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV AIDS (Auckl) 2017; 9: 153-159.
38.
Nance RM, Delaney JAC, Simoni JM, et al. HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: a cohort study. Ann Intern Med 2018; 169: 376-384.
39.
Rupérez M, Pou C, Maculuve S et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother 2015; 70: 2639-2647.
40.
Parienti JJ, Massari V, Descamps D, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004; 38: 1311-1316.
41.
Zuo Z, Liang S, Sun X, et al. Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China. PLoS One 2016; 11: e0166661. DOI: 10.1371/journal.pone.0166661.
42.
Mengesha MM, Ajema D, Teshome A, Tura AK. The association between diagnosis disclosure and adherence to antiretroviral therapy among adolescents living with HIV in sub-Saharan Africa: a protocol for systematic review and meta-analysis. Syst Rev 2020; 9: 160. DOI: 10.1186/s13643-020-01420-8.
43.
National AIDS Control Organisation of India. ART Guidelines for HIV-Infected Adults and Adolescents. NACO 2013. Available at: https://naco.gov.in/sites/defa....
44.
Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence 2019; 13: 475-490.
45.
Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-895.
46.
Ammassari A, Trotta MP, Shalev N, Marconi P, Antinori A. Beyond virological suppression: the role of adherence in the late HAART era. Antivir Ther 2012; 17: 785-792.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
